Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults
Running, not enrolling · Not applicable
Conditions studied: Smoking Cessation
In brief
This study evaluates the feasibility, acceptability, and preliminary efficacy of "Forward to Quit" (F2Q), a person-centered mobile health (mHealth) smoking cessation intervention designed specifically for transgender adults. The intervention was developed in collaboration with transgender individuals and gender-affirming healthcare providers. The study includes usability testing and a remote single-arm pilot trial. Primary outcomes include feasibility and acceptability of both the intervention and remote biochemical verification of smoking cessation. Secondary outcomes include self-reported and biochemically verified smoking cessation, as well as changes in psychosocial factors such as social support and gender affirmation. The goal is to inform a future large-scale trial and address tobacco-related health disparities in transgender populations.
Key facts
- Study ID
- NCT07181551
- Run by
- University of Colorado, Denver
- People needed
- 47
- Starts
- 2025-10-14
- Expected to finish
- 2031-12-01
- Last updated by the study team
- 2026-06-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Identify with a gender different from sex assigned at birth
- 18+ years of age
- Report smoking at least 5 cigarettes per day
- Have smoked 100+ cigarettes in their lifetime
- Own a device that can access the Internet (e.g., tablet, smartphone)
- Speak English
- Be willing to submit biochemical samples to verify cessation
- Be willing to use a website-based intervention to help with quit attempt
- Be willing to set a quit date within 1 month of baseline assessment
- Be willing to complete 3 months post-baseline and 6 months post-baseline assessments
You may not qualify if…
- Do not meet inclusion criteria
- Medical conditions precluding use of the carbon monoxide (CO) monitor or salivary cotinine testing
- Current use of pharmacotherapies for nicotine dependence
- Enrollment in another tobacco cessation program
Where it is running
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.